Latest News - Danaher

Top Corporates Hub

Danaher

DHR | NYSE | United States
77
-8
Rank
$177.21B
Market Cap
$23.87B
-$ 0.01B
-0.04%
Revenue
$4.92B
+$ 1.02B
+26.15%
Earnings
61K
-2K
-3.17%
Employees
Danaher Corporation (DHR) To Release FQ3 Results on October 21

02.10.2025 06:55

Danaher Corporation (NYSE:DHR) is one of the Top Blue Chip Stocks to Buy At 52-Week Lows. On September 23, Danaher Corporation (NYSE:DHR) announced that it will release its fiscal third-quarter results on October 21, 2025. The company topped Wall Street estimates during its fiscal second quarter of 2025. It delivered a revenue of $5.94 billion, […]

Read More

Danaher: Balanced Portfolio With Upside Potential In 2026

01.10.2025 06:33

Danaher Corporation is undervalued, with strong fundamentals, robust free cash flow, and 12.7% upside. Click here to read why DHR stock is a Buy.

Read More

Here's Why Envista (NVST) is a Strong Value Stock

29.09.2025 13:40

Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.

Read More

1 of Wall Street’s Favorite Stock on Our Watchlist and 2 Facing Headwinds

24.09.2025 04:33

The stocks in this article have caught Wall Street’s attention in a big way, with price targets implying returns above 20%. But investors should take these forecasts with a grain of salt because analysts typically say nice things about companies so their firms can win business in other product lines like M&A advisory.

Read More

Modine Manufacturing Company (MOD): A Bull Case Theory

26.08.2025 08:12

We came across a bullish thesis on Modine Manufacturing Company on Stock Analysis Compilation’s Substack. In this article, we will summarize the bulls’ thesis on MOD. Modine Manufacturing Company’s share was trading at $138.72 as of August 15th. MOD’s trailing and forward P/E were 39.75 and 31.85, respectively according to Yahoo Finance. Modine Manufacturing is a thermal […]

Read More

AstroNova: A Textbook Case For Shareholder Activism

17.08.2025 01:45

Our AstroNova investment was predicated on the view that this was a low-risk "under-earner". So, what went wrong? Click here to find out.

Read More

Atai Capital Management Q2 2025 Letter

17.08.2025 01:20

Atai Capital Management reports a 32.8% Q2 gain, reviews key portfolio moves and lessons from past missteps. Read the full letter for insights and strategy.

Read More

Are Wall Street Analysts Predicting Danaher Stock Will Climb or Sink?

14.08.2025 15:42

After weak long-term price action, are analysts bullish or bearish on Danaher Corp stock?

Read More

[Latest] US Personalized Medicine Market Size/Share Worth USD 252.93 Billion by 2034 at a 17.32% CAGR: Custom Market Insights (Analysis, Outlook, Leaders, Report, Trends, Forecast, Segmentation, Growth Rate, Value, SWOT Analysis)

13.08.2025 02:30

[220+ Pages Latest Report] According to a market research study published by Custom Market Insights, the demand analysis of US Personalized Medicine Market size & share revenue was valued at approximately USD 56.37 Billion in 2024 and is expected to reach USD 66.13 Billion in 2025 and is expected to reach around USD 252.93 Billion by 2034, at a CAGR of 17.32% between 2025 and 2034. The key market players listed in the report with their sales, revenues and strategies are Illumina Inc., Precision

Read More

Charles River raises profit forecast on growing demand for drug development services

06.08.2025 11:55

The Wilmington, Massachusetts-based contract drug developer raised its 2025 adjusted profit forecast to $9.90 to $10.30 per share, compared with its previous projection of $9.30 to $9.80. Contract research organizations, which reported quarterly results over the last month, have all posted better-than-expected profit, reflecting a rebound in spending from pharmaceutical and biotech clients after a cautious stretch driven by tighter sector financing. "We are continuing to see clear signs that the biopharmaceutical demand is stabilizing, and in this environment, we are making gradual progress to return to organic revenue growth," Charles River CEO James Foster said.

Read More

Danaher Insiders Sold US$250m Of Shares Suggesting Hesitancy

05.08.2025 13:00

The fact that multiple Danaher Corporation ( NYSE:DHR ) insiders offloaded a considerable amount of shares over the...

Read More

Where this large cap portfolio manager see opportunity now

29.07.2025 08:00

Looking for a large-cap stock to invest in? In the video above, Macquarie Large Cap Growth Team senior portfolio manager Brad Klapmeyer shares some of the sectors and stocks he's taking a closer look at. To watch more expert insights and analysis on the latest market action, check out more Market Domination Overtime here.

Read More

Are You a Momentum Investor? This 1 Stock Could Be the Perfect Pick

25.07.2025 13:50

Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.

Read More

1 S&P 500 Stock with Competitive Advantages and 2 We Turn Down

25.07.2025 04:32

The S&P 500 (^GSPC) is home to the biggest and most well-known companies in the market, making it a go-to index for investors seeking stability. But not all large-cap stocks are created equal - some are struggling with slowing growth, declining margins, or increased competition.

Read More

Danaher Stock: Attractively Valued And Poised For Growth Acceleration

23.07.2025 09:50

Danaher Corporation thrives on bioprocessing demand & diagnostics resilience. Click for why, with solid execution & 80% recurring revenue, DHR offers upside.

Read More

Danaher Corp (DHR) Q2 2025 Earnings Call Highlights: Strong Cash Flow and Bioprocessing Growth ...

23.07.2025 07:04

Danaher Corp (DHR) reports robust free cash flow and bioprocessing growth, while navigating global trade tensions and Life Sciences segment challenges.

Read More

Danaher (DHR) Reports Q2: Everything You Need To Know Ahead Of Earnings

21.07.2025 03:07

Diversified science and technology company Danaher (NYSE:DHR) will be reporting earnings this Tuesday before market hours. Here’s what to look for.

Read More

Medical Filtration Company Benchmark Report 2025 | Merck KGaA, 3M, and Danaher Strengthen Medical Filtration Market Leadership Through Strategic Expansions, Spin-Offs, and Mergers

18.07.2025 14:32

The Medical Filtration Companies Quadrant offers a detailed analysis of the global medical filtration market, spotlighting key players, technological advancements, and market trends. This report categorizes the top 15 companies, including leaders like Merck KGaA, 3M, and Danaher, each excelling in areas such as healthcare and life sciences. Medical filtration is crucial for removing contaminants from fluids, ensuring safety and purity in applications like dialysis and drug delivery. Techniques i

Read More